Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Boehringer Ingelheim Animal Health USA Inc. et al. Post grant review
Case Number:
Case Type:
PGR
Status:
Institution Denied
Petitioner:
Boehringer Ingelheim Animal Health USA Inc. et al.
-
February 28, 2023
Vidal Wants To Hear More About PTAB's Ruling On Pig Vax IP
U.S. Patent and Trademark Office Director Kathi Vidal has used the relatively new director review process to order a panel of Patent Trial and Appeal Board judges to further explain a decision that had flat-out rejected a challenge to a patent issued to a Kansas State University foundation covering a new kind of pig vaccine.
-
August 18, 2022
Vidal Takes Up Boehringer's Failed Pig Vaccine IP Challenge
U.S. Patent and Trademark Office Director Kathi Vidal has revived Boehringer's unsuccessful challenge to a Kansas State University pig vaccine patent by announcing she'll review the Patent Trial and Appeal Board's decision not to evaluate the patent's validity.